Adam Clark, Mackenzie Tatananni

Articles by Adam Clark, Mackenzie Tatananni

Novo Nordisk Could Win the Oral GLP-1 Race Against Lilly. Why It Just Raised Guidance. - Barron's

Business May 7, 2026

Novo Nordiskhiked its annual guidance Wednesday as demand for its weight-loss pill helped the company maintain its foothold in the booming market for GLP-1 drugs. Copyright Β©2026Dow Jones & Comp...